Status: retired, Primitive. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3678523015 | Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3678525010 | Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Is a | Emtricitabine and tenofovir only product in oral dose form | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Plays role | Antiretroviral therapeutic role | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Is a | Emtricitabine- and tenofovir-containing product | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has active ingredient | Emtricitabine | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has active ingredient | Tenofovir disoproxil fumarate | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Is a | Emtricitabine- and tenofovir-containing product in oral dose form | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has active ingredient | Emtricitabine | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has BoSS | Emtricitabine | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has active ingredient | Tenofovir disoproxil fumarate | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has BoSS | Tenofovir disoproxil fumarate | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength numerator value | 136 | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has BoSS | Tenofovir disoproxil fumarate | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength numerator value | 136 | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has BoSS | Emtricitabine | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has active ingredient | Emtricitabine | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has active ingredient | Tenofovir | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Some | ||
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has precise active ingredient | Emtricitabine | false | Inferred relationship | Some | 2 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Has precise active ingredient | Tenofovir disoproxil fumarate | false | Inferred relationship | Some | 1 | |
Emtricitabine 200 mg and tenofovir disoproxil fumarate 136 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set